Navigation Links
Vasculight VS

ProductsVasculight VS
Company Lumenis Inc.
Item Vasculight VS
Features "No downtime," non-ablative procedure. SR head with large spot size (10 x 45 mm) is light and easy to use. Treats full face, chest, neck and hands for a more youthful looking appearance. Patient database with touch-screen controls and pre-programmed parameters can also be easily customized for individual treatments.
Description The Vasculight VS system improves the appearance of photo-aged skin, removes age spots (sun-induced freckles), most benign brown pigments, telangiectasias, and broken capillaries. This innovative new application of Intense Pulsed Light (IPLTM) treats pigmentary sun damage through a process called photorejuvenation. The unique, combined approach of IPL and the Nd:YAG Laser is optimized for deeper and superficial vessels, plus telangiectactic matting and hemosiderin staining.
Info Lumenis Inc.
Customer Service: 877-lumenis

Related medicine products :

1. Vasculight Elite
2. Vasculight SR
The Bio-Quant TROPONIN I test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of cardiac,troponin I (cTnI) in human serum specimens as an aid i...
... InstaTest IgE test kit is an immunochromatographic ... levels of immunoglobulin E in human serum ... commonly associated with allergic pathologies. It may ... some infections. Rapid detection of IgE using ...
... is an all new, completely re-engineered high performance ... LOWEST CROSSING PROFILE PTCA products available ... profile of only 0.17. Atriums all new HyperLite ... catheter ever!, ,Atriums new "Dura-Blend tip technology is ...
... The Veris physiological monitor offers a ... those specifically designed for pediatric and neonate ... up to 3T. Veris is the first ... needs of pediatric and neonate patient monitoring. ...
Medicine Products:
(Date:12/16/2009)... 16 Shoppers like knowing if their ... Argentina. But grocers have found it burdensome to ... laws requiring them to provide the information at ... easyCOOLnow.com for easily making grocery and ... provisions that require retailers of unprocessed fruits, vegetables ...
(Date:12/16/2009)... 16 A new software program developed by ... healthcare facilities to calculate their staffing needs as it ... allows inpatient healthcare facilities to calculate their mandatory ... ratios and receive a daily report as to how ... a leader in risk management in the healthcare industry, ...
(Date:12/16/2009)... In a random sampling of wood pallets used ... PA, numerous pallets tested positive for Listeria and ... create health hazards for consumers. The new ... testing conducted in the Washington-Baltimore area, further illustrating ... nation,s food supply from wood pallets. ,, The ...
(Date:12/16/2009)... procedures in cardiology. The idea of publishing an ESC ... European cardiovascular imagers, is therefore long awaited. The textbook ... a patient rather than technology-based approach, helping clinicians to ... of imaging. , The book is divided into ... of cardiac imaging and its clinical use in all ...
(Date:12/16/2009)... happens when the families of sick and dying hospitalized ... for them? How do pediatricians respond to such personal ... and spirituality help some patients and families cope with ... almost always the families and patients who raise the ... the current issue of Southern Medical Journal , ...
Breaking Medicine News(10 mins):Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 2Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 3Health News:New Tests Confirm Wood Pallets Harbor Deadly Food Poisoning Bacteria 4Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3Health News:Prayer on the hospital floor 2
... underreport the number of hot flashes that they experience by ... to poor verbal memory, according to a study by researchers ... is published online and will appear in the September/October issue ... first study to explore the relationship between objectively measured hot ...
... especially, the brew could boost heart health, study finds , , ... lovers: Drinking up to six cups a day of caffeinated ... new study shows. , In fact, coffee might even help ... results suggest that long-term, regular coffee consumption does not increase ...
... 16 /PRNewswire-FirstCall/ - SXC Health Solutions Corp.,("SXC" or the ... provider of,pharmacy benefits management services, announces that effective June ... Executive Officer (CEO),will retire from the position of CEO, ... Officer, will be appointed President and CEO.,Both will continue ...
... EDEN PRAIRIE, Minn., June 16 Through emotional ... Benatar and,Neil Giraldo helped the Starkey Hearing Foundation, ... a record $5,045,000 at its annual,"So the World ... at the,RiverCentre in Saint Paul, Minn. With money ...
... MELVILLE, N.Y., June 16 The Hain Celestial,Group, Inc. ... food and personal,care products company, today announced that Irwin ... NASDAQ Stock Market Opening Bell on,Wednesday, June 18th at ... been nearly 15 years since The Hain Celestial Group ...
... medicine in the 19th,& 20th century, Behavioral Medicine will take ... component of Behavioral Medicine, Dr. John ... Basmajian, Member of the Order of Canada, MONTREAL, ... trained Canada,s top Olympic athletes will be teaching a,workshop in ...
Other Medicine News:Health News:Hot flashes underreported and linked to forgetfulness 2Health News:Coffee Drinkers Might Live Longer 2Health News:Coffee Drinkers Might Live Longer 3Health News:SXC Health Solutions announces Mark Thierer to be named President & CEO 2Health News:Garth Brooks, Jon McLaughlin, and Pat Benatar and Neil Giraldo Raise Their Voices to Help Starkey Hearing Foundation Raise More Than $5 Million at Annual Fundraiser 2Health News:Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM) 2Health News:Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM) 3Health News:Hain Celestial to Open The NASDAQ Stock Market and Celebrate Summer With A Healthy Way of Life(TM) 4Health News:Biofeedback Workshops & Distance Learning Offer Credits and Training Options 2
(Date:12/16/2009)... Dec. 16 Savara, Inc., an inhalation drug ... second tranche in its Series A financing round, exceeding ... ,, Funds raised in the Series A round ... NanoCluster technology. ,, "We now have the runway ... of the NanoCluster technology," said Rob Neville, CEO of ...
(Date:12/16/2009)... Dec. 16 ChemoCentryx, Inc. today announced ... Phase 2 clinical trial of CCX354, an orally-bioavailable, ... the CCR1 chemokine receptor for the treatment of ... highly potent and selective antagonist of CCR1, a ... cells, such as monocytes and macrophages, associated with ...
(Date:12/16/2009)... -- , - ... a Total of Over,640 patients Ahead of ... NV (Euronext Brussels: THR), a biopharmaceutical company,focused ... treatments for eye,disease, vascular disease and cancer, ... of the second Phase III trial evaluating ...
Breaking Medicine Technology:Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 2ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 3ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 4ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatment of Rheumatoid Arthritis 5ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 1Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 2Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 5Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 6Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 7Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 8Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 9Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 10Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 11Finding a protective mechanism for retinal cells could save sight 14859 1Finding a protective mechanism for retinal cells could save sight 14859 2Bacterial ropes tie down shifting Southwest 10753 1Bacterial ropes tie down shifting Southwest 10753 2